EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endoscopic detection of signet ring cell carcinoma in CDH1 carriers: a 15-year single-centre experience

Omar Salehi, Douglas Tjandra, Jadon Karp, Alex Boussioutas

Familial Cancer · 06.07.2026 · 25 (3)

DOI: 10.1007/s10689-026-00586-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Familial Cancer, online erschienen am 06.07.2026. Verfasst von Omar Salehi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Familial Cancer Clinic, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. Hauptthemen laut MEDLINE: Carcinoma, Signet Ring Cell, Stomach Neoplasms, Cadherins, Antigens, CD. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Monash University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CDH1 pathogenic variant carriers are at high lifetime risk of hereditary diffuse gastric cancer (HDGC). Endoscopic surveillance is recommended for individuals who delay risk-reducing total gastrectomy, although detection of signet ring cell carcinoma (SRCC) remains challenging. No Australian cohort has reported real-world endoscopic performance with surgical correlation in this population. We performed a 15-year retrospective cohort study of adult CDH1 carriers undergoing esophagogastroduodenoscopy (EGD) at a tertiary familial cancer centre (2008–2023). Patients presenting with symptomatic invasive gastric cancer at initial endoscopy were excluded. Most EGDs were conducted as preoperative assessments prior to risk-reducing total gastrectomy, with a minority undertaken as longitudinal surveillance. Endoscopic findings, biopsy performance, surgical pathology, and postoperative outcomes were analysed. Eighty-two CDH1 carriers from 31 families underwent 136 EGDs (median 1 per patient). SRCC was detected endoscopically in 38 patients (46.3%), predominantly via random biopsies. Overall sensitivity for SRCC detection was 67.9%, with random biopsies outperforming targeted sampling. Most lesions were identified at the initial EGD. Sixty-nine patients (84.1%) proceeded to total gastrectomy; SRCC was confirmed in 56 (81.2%), with variable tumour burden (1–73 foci). Invasive disease beyond pT1a was uncommon (2.9%). Postoperative complications occurred in 43.5%, most frequently anastomotic strictures requiring dilatation; there were no procedure-related deaths. Although occult SRCC was common, invasive malignancy beyond pT1a was infrequent, suggesting that many intramucosal lesions may have a more indolent course than previously assumed. Detection of SRCC at endoscopy remains challenging; however, these findings support a more individualized, risk-adapted approach to CDH1 management. Longer-term prospective data are required to better define SRCC progression risk and guide decisions regarding surveillance and risk-reducing surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Signet Ring CellStomach NeoplasmsCadherinsAntigens, CDEndoscopy, Digestive SystemHumansFemaleMaleRetrospective StudiesMiddle AgedAdultGastrectomyAgedHeterozygoteBiopsy

Stichwörter der Autor:innen

CDH1Endoscopic surveillanceGastrectomyHereditary diffuse gastric cancerSignet ring cell carcinoma

Substanzen

CadherinsCDH1 protein, humanAntigens, CD

Autor:innen und Institutionen

  • Familial Cancer Clinic, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.
  • Department of Gastroenterology, Alfred Health, Melbourne, VIC, 3004, Australia.
  • School of Translational Medicine, Monash University, Melbourne, 3004, Australia.
  • Familial Cancer Clinic, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. alex.boussioutas@monash.edu.
  • Department of Gastroenterology, Alfred Health, Melbourne, VIC, 3004, Australia. alex.boussioutas@monash.edu.
  • School of Translational Medicine, Monash University, Melbourne, 3004, Australia. alex.boussioutas@monash.edu.

Förderung

  • Monash University

Zitieren

APA

Salehi, O., Tjandra, D., Karp, J., & Boussioutas, A. (2026). Endoscopic detection of signet ring cell carcinoma in CDH1 carriers: a 15-year single-centre experience. Familial Cancer, 25(3). https://doi.org/10.1007/s10689-026-00586-9

Vancouver

Salehi O, Tjandra D, Karp J, Boussioutas A. Endoscopic detection of signet ring cell carcinoma in CDH1 carriers: a 15-year single-centre experience. Familial Cancer. 2026;25(3). doi:10.1007/s10689-026-00586-9

BibTeX
@article{Salehi2026,
  author = {Salehi, Omar and Tjandra, Douglas and Karp, Jadon and Boussioutas, Alex},
  title = {Endoscopic detection of signet ring cell carcinoma in CDH1 carriers: a 15-year single-centre experience},
  journal = {Familial Cancer},
  year = {2026},
  volume = {25},
  number = {3},
  doi = {10.1007/s10689-026-00586-9}
}
Kostenlos starten →